Table 2.
Target population
Target population in Geroscience trial | Definition | Potential indications |
---|---|---|
Subjects at risk of age-related diseases | Age-related diseases: Defined as disease with increased incidence in old age and generated by chronic impairment of the hallmark of aging | Atherosclerosis, cardio-vascular disease, cancer, osteo-arthritis, osteoporosis, type 2 diabetes, hypertension, cataract, Alzheimer’s disease, pre-eclampsia, others |
Subjects with accelerated aging-like states | Accelerated aging disease: Genetic disorder that result in accelerated aging-like states | Down syndrome, progeria, Werner syndrome |
Subject facing an accelerated aging-like condition | Accelerated aging condition: Clinical condition that results in accelerated phenotypic or biological aging | Immobilization, radiation, chemotherapy, exposure to toxins (tobacco, alcohol…), surgery, cardiopulmonary bypass surgery, hypoxia, prematurity, space flight, others |
Subjects at risk of geriatric syndromes | Geriatric syndrome: Group of age-related acute or chronic common health condition that are associated with poor resilience | Delirium, fall, functional limitation, undernutrition, frailty, sarcopenia, cognitive impairment, depression, others |
Subjects with (or at risk of) declining Intrinsic capacity (IC) | Intrinsic capacity: Concept that represents the composite of all physical and mental capacities | Older adult with abnormal IC domains (mobility, sensory, mood, cognition, vitality) as defined by WHO |